Details for Patent: 8,759,372
✉ Email this page to a colleague
Which drugs does patent 8,759,372 protect, and when does it expire?
Patent 8,759,372 protects NURTEC ODT and is included in one NDA.
This patent has forty-two patent family members in twenty-four countries.
Summary for Patent: 8,759,372
| Title: | N-(5S,6S,9R)-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-ctclohepta- [b]Pyridin-9-yl-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-carboxylat- e salt |
| Abstract: | Disclosed is a hemisulfate salt of Compound (I): ##STR00001## and crystalline forms of the hemisulfate salt. Also disclosed are methods of using the hemisulfate salt of Compound (I) as a CGRP receptor antagonist, and pharmaceutical compositions comprising the hemisulfate salt of Compound (I). The hemisulfate salt of Compound (I) is useful in treating, preventing, or ameliorating disorders including migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases such as asthma, and chronic obstructive pulmonary disease (COPD). |
| Inventor(s): | Roberts; Daniel Richard (Robbinsville, NJ), Schartman; Richard Raymond (Wallingford, CT), Wei; Chenkou (Princeton Junction, NJ) |
| Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
| Application Number: | 13/775,528 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,759,372
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | NURTEC ODT | rimegepant sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 212728-001 | Feb 27, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,759,372
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013226361 | ⤷ Try a Trial | |||
| Brazil | 112014021032 | ⤷ Try a Trial | |||
| Canada | 2865585 | ⤷ Try a Trial | |||
| China | 104136437 | ⤷ Try a Trial | |||
| Cyprus | 1119448 | ⤷ Try a Trial | |||
| Denmark | 2820016 | ⤷ Try a Trial | |||
| Denmark | 3254681 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
